ACT CAPITAL MANAGEMENT, LLC - MEDICENNA THERAPEUTICS CORP ownership

MEDICENNA THERAPEUTICS CORP's ticker is MDNA and the CUSIP is 58490H107. A total of 21 filers reported holding MEDICENNA THERAPEUTICS CORP in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
ACT CAPITAL MANAGEMENT, LLC ownership history of MEDICENNA THERAPEUTICS CORP
ValueSharesWeighting
Q3 2022$124,000
-28.3%
149,0700.0%0.17%
-29.3%
Q2 2022$173,000
-11.3%
149,070
-2.2%
0.24%
+17.5%
Q1 2022$195,000
-21.7%
152,5000.0%0.21%
+14.4%
Q4 2021$249,000
-74.3%
152,500
-56.4%
0.18%
-64.2%
Q3 2021$970,000
-8.0%
350,0000.0%0.50%
-7.2%
Q2 2021$1,054,000350,0000.54%
Other shareholders
MEDICENNA THERAPEUTICS CORP shareholders Q1 2022
NameSharesValueWeighting ↓
ACT CAPITAL MANAGEMENT, LLC 350,000$1,054,0000.54%
AIGH Capital Management LLC 915,000$2,768,0000.50%
AWM Investment Company, Inc. 1,000,000$3,017,0000.30%
Board of Trustees of The Leland Stanford Junior University 962,932$2,898,0000.27%
Worth Venture Partners, LLC 215,030$647,0000.24%
SILVERARC CAPITAL MANAGEMENT, LLC 110,515$333,0000.15%
INTACT INVESTMENT MANAGEMENT INC. 385,600$1,427,0000.04%
Verition Fund Management LLC 539,051$1,623,0000.02%
Patriot Financial Group Insurance Agency, LLC 22,900$69,0000.01%
Maven Securities LTD 79,118$234,0000.01%
View complete list of MEDICENNA THERAPEUTICS CORP shareholders